May 3, 2018 / 8:24 PM / 18 days ago

BRIEF-Ironwood And Allergan Announce Settlement With Aurobindo Pharma Resolving Linzess Patent Litigation

May 3 (Reuters) - Allergan plc:

* IRONWOOD AND ALLERGAN ANNOUNCE SETTLEMENT WITH AUROBINDO PHARMA RESOLVING LINZESS (LINACLOTIDE) PATENT LITIGATION

* SETTLEMENT WITH AUROBINDO IS SECOND PATENT INFRINGEMENT SETTLEMENT COMPANIES HAVE REACHED WITH RESPECT TO LINZESS

* IRONWOOD, CO TO GRANT AUROBINDO PHARMA LICENSE TO MARKET GENERIC VERSION OF LINZESS IN UNITED STATES BEGINNING ON AUG 5, 2030

* ALL ONGOING HATCH-WAXMAN LITIGATION BETWEEN COMPANIES AND AUROBINDO PHARMA REGARDING LINZESS PATENTS WILL BE DISMISSED

* ADDITIONAL DETAILS REGARDING SETTLEMENT WERE NOT DISCLOSED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below